ArticleOncoTargets and therapy2019

Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma by downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 expression.

Min Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.